The molecular pathogenesis of the Philadelphia-positive leukemias: implications for diagnosis and therapy.
Van Etten
R A
RA
Harvard Medical School, Center for Blood Research, Boston, MA 02115.
D000818:Animals; D016026:Bone Marrow Transplantation; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006412:Hematopoietic Stem Cells; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics* / Q000628:therapy; D054438:Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / Q000235:genetics; D051379:Mice; D010677:Philadelphia Chromosome; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics* / Q000628:therapy; D011519:Proto-Oncogenes
D016044:Fusion Proteins, bcr-abl